Wellington Management

Lumafield specializes in industrial computed tomography (CT) solutions, providing advanced non-destructive testing and inspection tools for engineers. The company's flagship product, the Neptune X-ray CT scanner, offers detailed imaging that allows engineers to analyze internal structures and identify defects in various materials. Complementing this hardware is the Voyager software platform, which facilitates cloud-based, AI-powered analysis, enabling automated inspections and collaborative efforts among teams. Additionally, Lumafield's Triton system is designed for high-speed scanning, catering to the needs of high-volume manufacturing environments. The company serves diverse industries, including aerospace, automotive, electronics, and medical devices, aiming to enhance product quality and reliability throughout the product development process.

MedinCell is an injectable slow-release drug specialist company.

Tabby Inc. is a financial technology company based in the United Arab Emirates that offers payment solutions for online purchases. It operates a platform that provides customers in the UAE and Saudi Arabia with a buy now, pay later option, allowing them to make payments for their purchases either in a single deferred payment or through multiple installments. This service aims to enhance financial flexibility, enabling consumers to manage their spending more effectively while ensuring safe payment transactions. Through its innovative approach, Tabby seeks to reshape the relationship individuals have with their finances, promoting a more accessible shopping experience.

Swanston Labs builds data-driven solutions aimed at disrupting the convergence of media, entertainment, technology, and commerce. The company focuses on leveraging innovative technologies to address the $7 trillion global leisure spending market. Swanston Labs operates under the Swanston Organization, which also includes Swanston Family Ventures and Swanston Philanthropy, collectively advancing the mission of innovation and inclusion.

Helicore Biopharma is at the forefront of developing cutting-edge treatments for obesity and related disorders.

Genius Sports Group Limited, founded in 2000 and headquartered in London, is a leading provider of technology-driven solutions in the sports data and betting industries. Through its subsidiaries, the company offers a range of services, including sports data software for leagues and governing bodies, live betting products, and personalized marketing campaigns for the sports betting sector. Genius Sports has established itself as a trusted partner to numerous international sports organizations, including major federations and professional leagues. Its commitment to the integrity and commercialization of sports data is central to its operations, emphasizing collaboration between sports organizations and data users to ensure both protection and opportunity maximization. The company's offerings are categorized into three main areas: Sports Technology and Services, Betting Technology, and Media Technology, all supported by a robust proprietary data infrastructure. Genius Sports primarily generates revenue from its Betting Technology division and has a significant presence in the European market.

Thoras.ai is an AI cloud management platform..It helps to detection, monitor performance, and manage costs.

Current is a consumer fintech banking platform dedicated to enhancing financial access for everyday Americans. The company focuses on developing integrated solutions that address the barriers preventing individuals from achieving their financial goals. With a commitment to simplifying the banking experience, Current aims to empower users to build a more secure financial future. The platform is supported by notable investments from various firms, reflecting its potential impact in the fintech space.

nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques.

AMP is an AI technology company that modernizes recycling infrastructure through smart sortation solutions. The company focuses on maximizing resource recovery while minimizing labor costs for waste management operations. With numerous deployments globally, AMP aims to transform the economics of recycling.

Metsera is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for obesity and metabolic conditions. The company focuses on advancing a variety of oral and injectable treatment options, including incretin, non-incretin, and combination therapies. These treatments are designed to address multiple therapeutic targets, positioning Metsera to meet the evolving demands of the weight loss treatment landscape. Additionally, Metsera integrates proprietary health technology tools to provide personalized care, enhancing the effectiveness of its therapeutic offerings.

Beta Bionics is a biotechnology company focused on developing an integrated bionic pancreas system known as the iLet. This innovative device aims to alleviate the challenges and costs associated with diabetes care by providing a dual-chamber infusion pump that delivers insulin and glucagon with precision. The iLet autonomously calculates and administers the necessary doses, enabling patients to effectively manage their blood sugar levels. The system has received breakthrough designation for all its configurations, including insulin-only, glucagon-only, and bihormonal options, and is compatible with Zealand Pharma’s dasiglucagon, a glucagon analogue known for its stability in a ready-to-use aqueous solution. Through this technology, Beta Bionics seeks to improve the quality of life for individuals living with diabetes.

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines targeting verified biology to improve care for patients with solid tumors.

Crisp, Inc. is a technology company based in Brooklyn, New York, specializing in demand forecasting software tailored for the food industry. Founded in 2018, Crisp connects consumer packaged goods (CPG) companies to real-time point-of-sale and inventory data from over 40 retailers and distributors. This integration allows Crisp to deliver actionable insights and analytics through business intelligence tools and interactive dashboards. Nearly 6,000 CPGs utilize Crisp’s platform to gain critical sales and supply chain insights, helping them streamline operations and enhance their market performance. The company aims to minimize waste across the food supply chain while equipping brands and retailers with the necessary data to facilitate growth.

Trace Machina is a company that specializes in the development and maintenance of simulation infrastructure, it is an open source software company that focuses on developing advanced technologies like AI, robotics, and autonomous mobility to reduce simulation costs for safety-critical systems.

Abnormal Security Corporation specializes in cloud-based email security solutions for Microsoft Office 365 and G Suite, aiming to protect organizations from targeted email attacks. Founded in 2018 and based in San Francisco, the company employs a data science approach to enhance its email protection capabilities. Its platform offers a range of services, including inbound email protection, detection of email account compromises, and responses to various threats. Abnormal Security addresses issues such as credential phishing, internal phishing, impersonation of employees and executives, vendor account compromise, as well as invoice and payment fraud. The company serves diverse sectors, including financial services, healthcare, and utilities, providing comprehensive solutions to safeguard against email-related risks that can lead to significant financial and reputational damage.

Day One Biopharmaceuticals is a clinical-stage biotechnology company that specializes in developing targeted cancer therapies for patients of all ages, with a particular focus on pediatric patients. Recognizing the advancements in cancer research, the company aims to create treatments that can benefit both children and adults diagnosed with genetically defined cancers. Day One Biopharmaceuticals prioritizes the rapid development of therapies to meet the urgent needs of families facing cancer diagnoses. Their lead product candidate, DAY101, is an oral, highly-selective pan-RAF kinase inhibitor designed to penetrate the brain, addressing a significant treatment gap in pediatric oncology. By licensing and acquiring promising products from research institutions and other companies, Day One Biopharmaceuticals strives to bring effective medicines to market for those impacted by cancer.

TS Conductor focuses on high-performance conductors designed for modern power grids, utilizing innovative transmission technology that features a carbon-fiber-composite core instead of traditional steel. This advancement results in conductors that are both lighter and stronger, enabling them to carry greater electrical currents with reduced energy loss and enhanced efficiency. The company manufactures covered conductors with an aluminum encapsulation, which safeguards the composite core from damage and corrosion. This design not only increases the capacity and reliability of electricity transmission and distribution but also promotes sustainability within the energy sector in a cost-effective manner.

Savara is an orphan lung disease company. Savara’s pipeline comprises Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, or GM-CSF, in Phase 3 development for autoimmune pulmonary alveolar proteinosis, or aPAP, in Phase 2a development for nontuberculous mycobacteria, or NTM, lung infection, and in preparation for Phase 2a development in cystic fibrosis, or CF, affected individuals with chronic NTM lung infection; and AeroVanc, a Phase 3 stage inhaled vancomycin for treatment of persistent methicillin resistant staphylococcus aureus, or MRSA, lung infection in CF. Savara’s strategy involves expanding its pipeline of potentially best-in-class products through indication expansion, strategic development partnerships and product acquisitions, with the goal of becoming a leading company in its field. The most recent acquisition is aerosolized amikacin/fosfomycin, a Phase 2 ready, proprietary combination antibiotic, which has demonstrated potent and broad-spectrum antibacterial activity against highly drug resistant pathogens. Savara’s management team has significant experience in orphan drug development and pulmonary medicine, identifying unmet needs, developing and acquiring new product candidates, and effectively advancing them to approvals and commercialization.

GrayMatter Robotics specializes in addressing complex surface treatment and finishing challenges encountered by manufacturers with high-mix, high-variability production needs. The company develops advanced robotics equipped with proprietary artificial intelligence, which are integrated into smart robotic cells. These systems are designed to assist human operators in performing tedious and ergonomically challenging tasks, thereby enhancing operational efficiency and productivity. By leveraging its innovative technologies, GrayMatter Robotics aims to streamline manufacturing processes, making them more effective and user-friendly for clients in various industries.

Cargo Therapeutics is a clinical-stage biotechnology company focused on developing next-generation CAR T-cell therapies aimed at overcoming cancer treatment resistance and improving patient access to potentially curative options. The company aims to enhance treatment outcomes by addressing the limitations of existing therapies, which currently provide curative benefits to less than half of cancer patients. Its lead program, CRG-022, is a novel CAR T-cell product candidate that targets CD22, a tumor antigen prevalent in many B-cell malignancies. By tackling issues such as limited durability, safety concerns, and supply chain obstacles, Cargo Therapeutics is committed to advancing innovative solutions that make effective cancer treatments more accessible to patients.

Scale AI, Inc. develops a data platform that specializes in providing training and validation data for artificial intelligence applications. Founded in 2016 and based in San Francisco, the company offers various annotation platforms, including Scale 3D Sensor Fusion for 3D sensor data, Scale Image for images, Scale Video for videos, Scale Text for text annotation, and Scale Document for intelligent document processing. These products facilitate a range of tasks such as content moderation, transcription, and data comparison across multiple sectors, including autonomous vehicles, e-commerce, conversational AI, and robotics. By enabling companies to focus on building advanced AI models rather than labeling data, Scale AI supports clients in accelerating the development of their artificial intelligence applications.

Bluejay Therapeutics is a biopharmaceutical company dedicated to developing cures for infectious diseases, with a primary focus on chronic Hepatitis B. This condition poses a significant global health challenge, and the company aims to address the urgent need for effective treatments. Bluejay is advancing two innovative therapeutic approaches: best-in-class fully human IgG1 anti-HBs monoclonal antibodies and first-in-class oral small molecule inhibitors targeting HBsAg. These strategies are designed to reduce hepatitis B surface antigen levels and restore adaptive immunity, potentially leading to a functional cure for patients. Additionally, the company’s research encompasses therapeutic options for chronic Hepatitis D, further solidifying its commitment to improving immunity and recovery for individuals affected by serious viral and liver diseases.

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients. The company is headquartered in Florida, USA.

Wiz, Inc. is a cybersecurity company founded in 2020 and headquartered in Palo Alto, California, with an additional office in Tel Aviv, Israel. The company specializes in cloud security, providing a platform that enables enterprises to identify and address security issues within their public cloud infrastructure. Its innovative solution offers a comprehensive view of security risks across various environments, including clouds, containers, and workloads. By utilizing a cloud-native visibility approach, Wiz delivers detailed risk assessments and root cause analyses through an agentless system, allowing security teams to gain actionable insights and effectively manage their cloud security posture.

BridgeBio Oncology Therapeutics operates as a biopharmaceutical company.

Asher Biotherapeutics, Inc. is a biotechnology company based in South San Francisco, California, founded in 2019. The company specializes in the development of immunotherapy drugs aimed at effectively treating cancer. Its innovative therapies are designed to enhance the immune system's ability to target and eliminate cancer cells while minimizing side effects. This focus allows healthcare providers to deliver effective treatments to patients in a shorter timeframe, aiming to improve overall outcomes in cancer care.

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy to every patient with cancer.The company's next-generation cell and gene therapies with pharmacologic operating systems provide exquisite control of protein activity in cells and create adoptive cell therapies with new functions that are under control of the treating physician using simple, safe, orally-active, marketed drugs, enabling patients to improve on the current generation of cell therapies.

Avidity Biosciences, Inc. is a biotechnology company focused on developing oligonucleotide-based therapies known as antibody oligonucleotide conjugates (AOCs). These innovative therapies aim to address the limitations of traditional oligonucleotide treatments by combining the tissue selectivity of monoclonal antibodies with the precision of oligonucleotide therapies. This approach allows Avidity to target previously undruggable tissue and cell types, thereby addressing the underlying genetic drivers of various diseases. The company's lead product candidate, AOC 1001, is designed to treat myotonic dystrophy type 1, a rare muscle disease. Additionally, Avidity is advancing multiple programs aimed at treating muscle-related conditions such as muscle atrophy, Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy, and Pompe disease. Founded in 2012 and based in La Jolla, California, Avidity is also exploring therapeutic applications in immune and other cell types.

AssetWatch specializes in proactive and predictive maintenance solutions aimed at preventing unplanned downtime for global manufacturers. The company offers an extensive remote condition monitoring service that integrates wireless sensors and communication hubs with sophisticated software. These wireless vibration and temperature sensors gather critical machine health data, which is analyzed using machine learning algorithms and the expertise of condition monitoring engineers. This analysis provides actionable insights that go beyond simple pass/fail assessments, enabling manufacturers to transition from a reactive to a proactive maintenance culture. By delivering prescriptive recommendations, AssetWatch supports manufacturers in optimizing their maintenance processes and enhancing operational reliability.

Quince, LLC is a retail company based in San Francisco, California, specializing in affordable luxury apparel, accessories, and home goods for both men and women. Founded in 2016, Quince offers a diverse range of products including jewelry, tops, sweaters, loungewear, leather goods, and various accessories for men, as well as bedding and bath items for the home. The company employs a manufacturer-to-consumer retail model, producing inventory on a near just-in-time basis, which allows for direct shipping to consumers. This approach not only reduces costs but also minimizes financial and environmental waste, enabling Quince to provide high-quality fashion and home products at competitive prices.

Binkey is a financial technology company that helps merchants to accepts FSA and HSA as a form of payment.

Tabby Inc. is a financial technology company based in the United Arab Emirates that offers payment solutions for online purchases. It operates a platform that provides customers in the UAE and Saudi Arabia with a buy now, pay later option, allowing them to make payments for their purchases either in a single deferred payment or through multiple installments. This service aims to enhance financial flexibility, enabling consumers to manage their spending more effectively while ensuring safe payment transactions. Through its innovative approach, Tabby seeks to reshape the relationship individuals have with their finances, promoting a more accessible shopping experience.

Avalyn Pharma is a biopharma company that advances therapies for the treatment of Idiopathic Pulmonary Fibrosis (IPF) and other severe respiratory diseases. Its therapies rapidly advance AP01 for the treatment of IPF, provides additional pipeline candidates for IPF, improve the care and outcomes of severe respiratory diseases, and develop novel inhaled therapeutics. Avalyn Pharma was established in 2011 and is headquartered in Seattle, Washington.

Fore Biotherapeutics is a clinical-stage biotechnology company focused on developing precision oncology treatments tailored to patients with specific genetic mutations. By utilizing functional genomics, the company aims to create a pipeline of therapies that address unmet needs in cancer care. Fore Biotherapeutics conducts research to replicate naturally occurring mutations in vitro, allowing for the assessment of their impact on cellular signaling pathways and responses to various compounds. This approach not only facilitates the identification of novel target mutations but also helps biopharma companies broaden the patient subgroups that may benefit from existing cancer therapies.

Trove is a leading company in the branded resale and trade-in industry, primarily based in Ann Arbor, Michigan. The company provides a sophisticated platform that enables brands to efficiently launch, manage, and scale their resale programs, capturing over 75% of the U.S. branded resale market. Trove's platform offers advanced tools for in-store and digital trade-ins, returns processing, and inventory management, which empower brands to connect with diverse customer demographics and optimize their resale strategies through comprehensive analytics. Trove collaborates with notable brands, including Canada Goose, Michael Kors, and Patagonia, enhancing their ability to manage non-new inventory and enabling peer-to-peer sales. As a Certified B Corporation, Trove emphasizes sustainability in retail, aiming to combine commerce with environmental responsibility and drive the industry toward a more sustainable future.

Skims is a brand focused on creating innovative underwear, loungewear, and shapewear designed to enhance body shape. The company manufactures and retails a diverse range of products, including bodysuits, shapewear, and underwear, tailored to various body types. By offering a variety of styles and color shades, Skims aims to provide women with the appropriate support and coverage they need.

MUSINSA is a fashion business company that offers personalized curation and storytelling for various brands and products. Its platform helps brands and consumers' lifestyles by designing, creating, enjoying, and interacting with fashion. It also delivers fashion trends and information to help customers engage and interact.

Orennia provides trusted commercial analytics to help inform investment and capital allocation decisions for renewable and zero-carbon energy. Orennia's insights, curated by highly experienced industry experts, help investors in the renewable power sector accelerate their time-to-value and make confident investment decisions.

Caraway is a digital healthcare company for college women+ that provides integrated mental, reproductive and physical healthcare services. Built with students for students, Caraway arms women+ with the first personalized, equitable and digitally-accessible care solution that prioritizes their needs and concerns. With an unprecedented need for mental health resources and new barriers and persistent inequities in women’s+ health, Caraway provides access to trusted, holistic, and compassionate healthcare so women+ can get the care they need when they need it.

Upstream Bio is a clinical-stage biotechnology company dedicated to developing antibody therapies for inflammatory diseases, particularly severe asthma and other respiratory disorders. The company's lead candidate, verekitug, is a monoclonal antibody that acts as an antagonist to the Thymic Stromal Lymphopoietin (TSLP) receptor. TSLP is a key cytokine that drives inflammatory responses and is strategically positioned upstream of various signaling pathways influencing immune cells. Upstream Bio aims to address unmet medical needs in the treatment of severe respiratory conditions by leveraging this validated target to create effective therapies.

Alkeus Pharmaceuticals is a Boston-based clinical-stage biopharmaceutical company dedicated to developing treatments for serious and untreatable ophthalmic conditions. The company's primary focus is on its lead drug candidate, an orally delivered compound aimed at addressing Stargardt disease and age-related macular degeneration. This innovative treatment has the potential to help medical professionals manage symptoms of irreversible vision loss early in life, offering hope to patients affected by these debilitating eye diseases.

EVgo operates a public fast-charging network for electric vehicles in the United States, providing essential charging infrastructure for both consumers and businesses. Its network features fast chargers that can deliver up to 90 miles of range in just 30 minutes and is compatible with all electric vehicle models that utilize DC fast charging. To expand its reach, EVgo partners with a variety of organizations, including grocery store chains, automotive manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners. This collaborative approach allows EVgo to effectively deploy its charging stations in convenient locations, enhancing accessibility for electric vehicle drivers.

Boundless Bio is a clinical-stage biopharmaceutical company focused on developing innovative therapies for the treatment of aggressive cancers linked to extrachromosomal DNA (ecDNA). Founded in 2018 and based in La Jolla, California, the company aims to address the significant unmet medical needs of patients with oncogene amplified tumors, which affect over 14% of cancer patients. By targeting ecDNA, a key factor in oncogene amplification, Boundless Bio seeks to provide transformative treatments for previously difficult-to-treat cancers. One of its leading candidates, BBI-355, is an oral, selective inhibitor of checkpoint kinase 1 (CHK1), designed to manage the replication and transcription of ecDNA in cancer cells.

Quince, LLC is a retail company based in San Francisco, California, specializing in affordable luxury apparel, accessories, and home goods for both men and women. Founded in 2016, Quince offers a diverse range of products including jewelry, tops, sweaters, loungewear, leather goods, and various accessories for men, as well as bedding and bath items for the home. The company employs a manufacturer-to-consumer retail model, producing inventory on a near just-in-time basis, which allows for direct shipping to consumers. This approach not only reduces costs but also minimizes financial and environmental waste, enabling Quince to provide high-quality fashion and home products at competitive prices.

AMP is an AI technology company that modernizes recycling infrastructure through smart sortation solutions. The company focuses on maximizing resource recovery while minimizing labor costs for waste management operations. With numerous deployments globally, AMP aims to transform the economics of recycling.

Clerkie is an AI-driven financial planning platform designed to assist Americans in managing their debt and enhancing their financial literacy. The company utilizes a proprietary financial automation system that incorporates conversational AI to create detailed financial knowledge graphs. This technology allows users to easily understand their financial situations and take actionable steps toward debt management. By combining expert financial advice with automated solutions, Clerkie aims to simplify the process of addressing debt burdens, making it more accessible for individuals to implement effective financial strategies.

Saluda Medical is a commercial-stage medical device company focused on developing innovative treatments for chronic neurological conditions, particularly chronic neuropathic pain. The company utilizes a unique closed-loop neuromodulation platform that senses and measures neural responses to stimulation. This technology automatically adjusts the therapy based on real-time neurophysiological feedback, allowing for personalized treatment tailored to each patient's specific needs. By monitoring the patient's neural fingerprint, Saluda Medical’s devices enable the precise delivery of electrical stimulation, ultimately improving the management of chronic back pain and enhancing patient outcomes.

HeartFlow, Inc. is a medical technology company that specializes in non-invasive solutions for coronary artery disease detection. Founded in 2007 and based in Redwood City, California, with additional offices in Portland, Austin, London, and Tokyo, the company offers its HeartFlow Analysis, which utilizes data from standard computerized tomography scans to create personalized three-dimensional models of a patient's heart. This analysis helps clinicians evaluate the impact of blockages on blood flow, facilitating informed treatment decisions while minimizing the need for invasive testing. HeartFlow's technology integrates over two decades of scientific research with advancements in artificial intelligence, making its HeartFlow FFRCT Analysis available in the United States, Canada, Europe, the United Kingdom, and Japan.

Span.IO designs and develops innovative residential energy storage solutions aimed at facilitating the adoption of renewable energy. The company's flagship product includes a smart electrical panel that replaces traditional panels, providing an intuitive interface for managing home energy use. This system allows users to monitor and control energy consumption remotely through a dedicated application, enhancing the overall consumer experience. Span.IO's team, composed of experts in energy, software, hardware, and consumer finance, leverages their collective knowledge in power generation and system integration to create products that promote environmental sustainability and energy efficiency. Through its technology, Span.IO aims to transform the energy sector by making home energy management more accessible and automated.

Chroma Medicine is a genomic medicine company based in Cambridge, Massachusetts, founded in 2021. The company focuses on epigenetic editing, aiming to revolutionize the treatment of genetically driven diseases. By utilizing epigenetics, which is nature's inherent mechanism for regulating genes, Chroma Medicine develops programmable epigenetic editors that target specific genes and control chromatin conformation. This innovative approach combines a DNA binding domain with epigenetic effector domains, providing medical practitioners with a new class of therapeutics that offers enhanced control over gene expression.

Cargo Therapeutics is a clinical-stage biotechnology company focused on developing next-generation CAR T-cell therapies aimed at overcoming cancer treatment resistance and improving patient access to potentially curative options. The company aims to enhance treatment outcomes by addressing the limitations of existing therapies, which currently provide curative benefits to less than half of cancer patients. Its lead program, CRG-022, is a novel CAR T-cell product candidate that targets CD22, a tumor antigen prevalent in many B-cell malignancies. By tackling issues such as limited durability, safety concerns, and supply chain obstacles, Cargo Therapeutics is committed to advancing innovative solutions that make effective cancer treatments more accessible to patients.

Dataiku Inc. is a company that develops a centralized data platform designed to support businesses in their data journey from analytics to enterprise AI. Founded in 2013, and headquartered in New York with additional offices in Paris and London, Dataiku offers a collaborative data science software platform known as Dataiku DSS. This platform enables teams of data scientists, analysts, and engineers to prepare, analyze, and visualize data effectively. It includes tools for data profiling, interactive exploration, and machine learning capabilities, allowing organizations to build and deploy data products efficiently. By providing a repository of best practices and a controlled environment, Dataiku aims to foster collaboration among data professionals and streamline the development of impactful models and innovative solutions. Prominent clients like Unilever and GE utilize Dataiku to enhance their data-driven decision-making processes and adapt to the growing volume of data they manage.

Rokt is a software development company that specializes in e-commerce technology designed to enhance the consumer purchasing experience by integrating marketing into the transaction moment. By connecting advertisers with customers, Rokt embeds native advertisements into the transaction flows of e-commerce sites, allowing businesses to engage consumers when they are most receptive to promotional messages or upsell opportunities. This approach aims to improve revenue for e-commerce operators while also delivering a more effective customer experience and fostering greater social engagement and cross-selling potential.

MBX Biosciences, Inc. is a biotechnology company based in Carmel, Indiana, specializing in the development of therapeutics for rare endocrine disorders. Established in 2018, the company focuses on creating peptides aimed at treating genetic diseases that affect glandular hormones, which play a crucial role in the body’s chemical messaging system. By targeting conditions with inadequate treatment options, MBX Biosciences is dedicated to discovering, developing, and commercializing innovative endocrine therapeutics.

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients. The company is headquartered in Florida, USA.

AMP is an AI technology company that modernizes recycling infrastructure through smart sortation solutions. The company focuses on maximizing resource recovery while minimizing labor costs for waste management operations. With numerous deployments globally, AMP aims to transform the economics of recycling.

immatics is a biopharmaceutical company focused on the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The company's customized Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics are the two main product classes in the pipeline (TCER). With a focus on particularly difficult-to-treat solid malignancies, each therapy modality has unique characteristics to create the desired therapeutic impact for patients at various disease stages and with various types of tumors. immatics biotechnologies was established in 2000 by Hans Rammensee, Harpreet Singh, and Steffen Walter in Tübingen, Baden-Wurttemberg.

RayzeBio, Inc. is a biotechnology company based in San Diego, California, founded in 2020. It specializes in developing tumor-targeted small molecule medicines that utilize the therapeutic potential of radioisotopes, particularly Actinium-225, an alpha-emitting radioisotope aimed at treating solid tumors. RayzeBio is focused on enhancing cancer treatment outcomes by creating a robust pipeline of radiopharmaceutical candidates targeting validated oncology drug targets. The company's portfolio includes a range of drug candidates at various stages of development, from discovery to late-stage clinical programs, addressing significant market opportunities in the field of cancer therapeutics.

Flavrs is a San Francisco-based shoppable video platform that merges premium food content with commerce, catering to food enthusiasts. Founded in 2020, the platform offers a variety of recipes, ranging from seafood to Thai cuisine, and features video tutorials created in collaboration with renowned chefs and food creators. Users can engage with these tutorials to learn how to reproduce the showcased meals at home. Flavrs enhances the cooking experience by providing a seamless shopping component, allowing users to purchase the necessary ingredients directly through a custom integration with Instacart. This innovative approach enables foodies to discover, replicate, and enjoy a diverse array of culinary creations.

SeatGeek, Inc. is a mobile ticketing marketplace and ticket search engine that facilitates the buying and selling of tickets for sports, concerts, and theater events. Founded in 2009 and headquartered in New York, the company also has offices in the United Kingdom, Israel, the Netherlands, Australia, and Italy. SeatGeek's platform aggregates ticket listings from various sources, allowing users to compare prices and find the best deals. Its unique 'Deal Score' feature rates tickets on a scale from 0 to 100, helping consumers assess the relative value of options for specific events. Additionally, SeatGeek offers an event discovery tool that generates personalized recommendations based on user preferences and favorite teams or artists. This combination of features enables fans to navigate the ticketing landscape efficiently and effectively.

Meati Foods is a Boulder, Colorado-based company specializing in the production and sale of fungi-based meat alternatives. Founded in 2016, the company aims to provide sustainable and nutritious plant-based options that serve as an alternative to traditional meat products. Meati Foods utilizes a proprietary fermentation process to create minimally processed steaks made from natural ingredients, ensuring its offerings are free from common allergens. The company markets its products online, making them accessible to a wide audience seeking vegan food choices that are both healthy and environmentally friendly.

Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.

FalconX, Ltd. is a cryptocurrency brokerage and digital asset trading platform founded in 2018 and based in San Mateo, California. The company specializes in providing trading solutions for blockchain and fintech sectors, focusing on reliable execution for its clients. Utilizing data science and machine learning, FalconX's platform aims to eliminate slippage and hidden fees, enabling efficient access to cryptocurrency markets. It serves hedge funds, proprietary trading firms, and other institutional clients by facilitating mid-to-large size trades with smart routing across various liquidity sources for optimal pricing.

Kinside gives parents everything they need to make work work: from securing a spot for your child, to paying for care online, and accessing tax savings and contributions from your employer.

Guild's lifelong learning platform offers classes, programs, and degrees for working adults, with a path for them to move forward in their education and careers. It offers these adults support from start to finish, with their technology platform for discovery, learning, and organizing the experience, and extra support with their tech-enabled student advising model.

Arcadia, Inc. is a technology company focused on providing access to clean energy through its online platform. Founded in 2014 and based in Washington, D.C., the company connects users—ranging from residential homes to businesses—with renewable energy sources, such as wind farms and community solar projects. Its application enables users to manage their accounts, track energy usage, and participate in clean energy initiatives in their area. By democratizing access to energy data from over 125 utilities across the United States, Arcadia empowers consumers to transition away from fossil fuels and supports efforts to address energy inequality. The company also operates a leading community solar program, which contributes significantly to renewable energy generation while promoting economic growth.

Span.IO designs and develops innovative residential energy storage solutions aimed at facilitating the adoption of renewable energy. The company's flagship product includes a smart electrical panel that replaces traditional panels, providing an intuitive interface for managing home energy use. This system allows users to monitor and control energy consumption remotely through a dedicated application, enhancing the overall consumer experience. Span.IO's team, composed of experts in energy, software, hardware, and consumer finance, leverages their collective knowledge in power generation and system integration to create products that promote environmental sustainability and energy efficiency. Through its technology, Span.IO aims to transform the energy sector by making home energy management more accessible and automated.

Omada Health, Inc. is a digital healthcare company that creates and implements online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, Omada Health focuses on helping employers and health plans identify individuals at risk for preventable chronic diseases such as prediabetes, diabetes, hypertension, and heart disease. The company offers personalized programs that adapt to the unique needs of participants, incorporating professional health coaching, connected health devices, and real-time data to foster sustainable lifestyle changes. Omada Health is recognized as the largest provider of the National Diabetes Prevention Program, delivering clinically effective solutions that empower individuals to take charge of their health and achieve their wellness goals.

Somatus, Inc. is a healthcare company based in McLean, Virginia, specializing in kidney care services. Founded in 2016, it partners with health plans, health systems, nephrology, and primary care groups to offer integrated care for patients with or at risk of developing kidney disease. The company provides a range of services, including home hemodialysis, peritoneal dialysis, in-center hemodialysis, kidney transplantation, and conservative care. Somatus focuses on delaying or preventing the progression of chronic kidney disease and aims to enhance the quality of care through improved coordination and increased utilization of home dialysis and transplantation options. Its approach combines vertically integrated clinical services and technology to optimize patient outcomes.

Synthego Corporation is a genome engineering company focused on advancing life science research and therapeutic development to improve human health. Founded in 2012 and headquartered in Redwood City, California, Synthego offers a comprehensive platform that integrates proprietary hardware, software, bioinformatics, chemistries, and molecular biology. The company's product portfolio includes engineered cells, CRISPR kits, and bioinformatics tools designed for various applications such as pathway analysis, target validation, disease modeling, and diagnostics. By leveraging machine learning and automation, Synthego enables researchers in biotechnology and academia to conduct efficient and precise gene editing, facilitating rapid advancements in drug discovery and development. The company serves a global customer base, distributing its products through various channels, including online sales and partnerships in multiple countries.

Creditas is a financial technology company that operates a digital platform that offers secured consumer loans. It uses credit scoring systems and borrowers’ assets, such as homes and automobiles as collateral to offer loans. Sergio Furio founded BankFacil in 2012 that later became Creditas. It has its headquarters in São Paulo in Brazil.

Go Digit General Insurance Limited is a digital insurance company based in Bengaluru, India, founded in 2016 by Kamesh Goyal. The company offers a wide range of insurance products, including car, travel, home, commercial vehicle, bike, health, mobile, and shop insurance, as well as flight delay coverage. Go Digit focuses on enhancing customer experience through its online platform, which facilitates claims, renewals, and provides information on motor vehicle and health insurance. The company is known for its innovative approach to insurance, aiming to simplify products and pricing processes. It operates as a subsidiary of Go Digit Infoworks Services Private Limited and generates significant revenue from its motor insurance offerings.

Dave Inc. is a financial services company that operates a mobile application designed to enhance users' financial well-being. Founded in 2015 and based in Los Angeles, California, the app alerts users to potential overdrafts, helps predict expenses, and provides access to up to $250 in overdraft protection. Additionally, it offers features such as credit building and resources for finding side jobs, enabling users to manage their finances more effectively. With a user base exceeding 12 million, Dave aims to provide banking services without hidden fees, acting as a supportive tool for individuals seeking to budget, access funds, and receive financial guidance. The application is available on both the App Store and Google Play.

Rokt is a software development company that specializes in e-commerce technology designed to enhance the consumer purchasing experience by integrating marketing into the transaction moment. By connecting advertisers with customers, Rokt embeds native advertisements into the transaction flows of e-commerce sites, allowing businesses to engage consumers when they are most receptive to promotional messages or upsell opportunities. This approach aims to improve revenue for e-commerce operators while also delivering a more effective customer experience and fostering greater social engagement and cross-selling potential.

Anchorage Digital is a regulated cryptocurrency platform that offers integrated financial services and infrastructure solutions tailored for institutions. Established in 2017 and headquartered in San Francisco, California, the company operates as the only federally chartered crypto bank in the United States, with an additional office in Singapore that maintains similar security and service standards. Anchorage Digital specializes in secure custody, regulatory compliance, and a variety of cryptocurrency-related services, including trading, staking, and governance. The platform emphasizes modern security engineering to ensure the safety of digital assets while facilitating streamlined participation in blockchain technology for businesses and institutions. With a valuation exceeding $3 billion, Anchorage Digital has attracted investments from prominent firms such as Andreessen Horowitz, Goldman Sachs, and Visa, among others. The company also supports a remote-friendly work environment, with additional offices located in New York, Porto, and Sioux Falls.

Juspay is a developer of an online platform designed to be used for mobile-based payments. The company's online platform is a SaaS layer on top of payment gateways to simplify integration, improve robustness and ease the management of diverse and rapidly evolving payment options, enabling users to make electronic transactions securely and efficiently.

Olist is a Brazilian company based in Curitiba that operates as an online e-commerce platform designed to support small and medium-sized businesses (SMBs) in navigating the complex digital marketplace landscape. It connects merchants with major online retailers, allowing them to advertise and sell their products on various marketplaces efficiently. Olist offers a comprehensive ecosystem that includes Olist Store, which facilitates sales on marketplaces, and Olist Shops, a mobile-first e-commerce solution integrated with social media and available in 180 countries. Additionally, Olist provides logistics services through Olist Pax, a cloud-based fulfillment network, and financial solutions via Olist Credit and Olist Pay. By streamlining the selling process and enhancing the shopping experience, Olist plays a pivotal role in empowering SMBs and expanding their reach to international markets.

Course Hero, Inc. operates an online learning platform that provides students and educators with access to a wide range of study materials. Founded in 2006 and based in Redwood City, California, the platform offers an extensive database of student-uploaded resources, including lecture notes, study guides, textbook solutions, practice problems, exams, and video lectures from various institutions. Additionally, Course Hero features an educator platform for sharing materials and collaborating, along with a flashcard application that enables users to search for existing sets or create their own. The company also connects students with expert tutors who respond to academic queries, fostering a comprehensive learning environment.

Chroma Medicine is a genomic medicine company based in Cambridge, Massachusetts, founded in 2021. The company focuses on epigenetic editing, aiming to revolutionize the treatment of genetically driven diseases. By utilizing epigenetics, which is nature's inherent mechanism for regulating genes, Chroma Medicine develops programmable epigenetic editors that target specific genes and control chromatin conformation. This innovative approach combines a DNA binding domain with epigenetic effector domains, providing medical practitioners with a new class of therapeutics that offers enhanced control over gene expression.

Faire is an online wholesale marketplace that connects retailers with unique merchandise from various brands and makers, facilitating a streamlined purchasing process. The platform provides retailers with tools and insights to manage inventory effectively, employing artificial intelligence and predictive analytics to forecast product demand. Faire's offerings include net 60 payment terms and free returns, which reduce the risks associated with wholesale purchasing, enabling local retailers and independent brands to compete with larger e-commerce entities. Headquartered in San Francisco and Kitchener, Faire aims to support the future of local retail by simplifying logistics and enhancing access to diverse products.